Gemina Laboratories Stock Performance
| GLABF Stock | USD 0.05 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of -1.72, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Gemina Laboratories are expected to decrease by larger amounts. On the other hand, during market turmoil, Gemina Laboratories is expected to outperform it. At this point, Gemina Laboratories has a negative expected return of -1.48%. Please make sure to check out Gemina Laboratories' jensen alpha, kurtosis, relative strength index, as well as the relationship between the value at risk and day median price , to decide if Gemina Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Gemina Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 881.9 K | |
| Total Cashflows From Investing Activities | 8197.00 |
Gemina |
Gemina Laboratories Relative Risk vs. Return Landscape
If you would invest 34.00 in Gemina Laboratories on November 1, 2025 and sell it today you would lose (29.00) from holding Gemina Laboratories or give up 85.29% of portfolio value over 90 days. Gemina Laboratories is currently producing negative expected returns and takes up 18.903% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Gemina, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Gemina Laboratories Target Price Odds to finish over Current Price
The tendency of Gemina Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.05 | 90 days | 0.05 | about 82.03 |
Based on a normal probability distribution, the odds of Gemina Laboratories to move above the current price in 90 days from now is about 82.03 (This Gemina Laboratories probability density function shows the probability of Gemina Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Gemina Laboratories has a beta of -1.72. This usually indicates as returns on its benchmark rise, returns on holding Gemina Laboratories are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Gemina Laboratories is expected to outperform its benchmark. Additionally Gemina Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Gemina Laboratories Price Density |
| Price |
Predictive Modules for Gemina Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gemina Laboratories. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Gemina Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Gemina Laboratories is not an exception. The market had few large corrections towards the Gemina Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Gemina Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Gemina Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | -1.72 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | -0.04 |
Gemina Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gemina Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gemina Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gemina Laboratories generated a negative expected return over the last 90 days | |
| Gemina Laboratories has high historical volatility and very poor performance | |
| Gemina Laboratories has some characteristics of a very speculative penny stock | |
| Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 56.0% of the company shares are held by company insiders |
Gemina Laboratories Fundamentals Growth
Gemina Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Gemina Laboratories, and Gemina Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gemina Pink Sheet performance.
| Return On Equity | -3.47 | |||
| Return On Asset | -1.48 | |||
| Operating Margin | 979.18 % | |||
| Current Valuation | 17.22 M | |||
| Shares Outstanding | 64.1 M | |||
| Price To Book | 9.70 X | |||
| Price To Sales | 5,790 X | |||
| EBITDA | (4.69 M) | |||
| Cash And Equivalents | 2.95 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 12.47 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (3.87 M) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 1.42 M | |||
About Gemina Laboratories Performance
By analyzing Gemina Laboratories' fundamental ratios, stakeholders can gain valuable insights into Gemina Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Gemina Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Gemina Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.Things to note about Gemina Laboratories performance evaluation
Checking the ongoing alerts about Gemina Laboratories for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Gemina Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gemina Laboratories generated a negative expected return over the last 90 days | |
| Gemina Laboratories has high historical volatility and very poor performance | |
| Gemina Laboratories has some characteristics of a very speculative penny stock | |
| Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 56.0% of the company shares are held by company insiders |
- Analyzing Gemina Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gemina Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Gemina Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gemina Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gemina Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gemina Laboratories' pink sheet. These opinions can provide insight into Gemina Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Gemina Pink Sheet analysis
When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |